Chimerix Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
48.03 M |
Public Float |
36.77 M |
Chimerix Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.37 |
Market Cap |
$205.82 M |
Shares Outstanding |
51.07 M |
Public Float |
44.26 M |
Address |
2505 Meridian Parkway Durham North Carolina 27713 United States |
Employees | - |
Website | http://www.chimerix.com |
Updated | 07/08/2019 |
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded by George R. |